We focus on areas where scientific innovation and technological change create meaningful investment opportunities. Our process combines domain expertise, fundamental analysis and an independent, long-term perspective.
Research across therapeutics, pharmaceuticals, diagnostics, medical technology, life-science tools and healthcare innovation. We examine biological mechanisms, clinical evidence, unmet need and commercial opportunity.
Research across semiconductors, computing infrastructure, networking, data centers, software and AI applications. We assess technical differentiation, ecosystem dynamics and long-term competitive advantage.
We pursue opportunities opportunistically rather than adhering to a fixed allocation between sectors. Investment decisions remain subject to research findings, valuation and risk considerations.